Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Booking Holdings Prices €3.55B Four-Tranche Euro Notes

Booking Holdings Inc. filed a free writing prospectus on November 9, 2026, disclosing final pricing terms for four tranches of euro-denominated senior unsecured notes totaling €3,550,000,000 in aggregate principal amount, with settlement expected on November 13, 2026.

Aakashdeep | 09 November 2026

STERIS Irish FinCo Prices $1.5B Senior Notes in Two Tranches

STERIS Irish FinCo Unlimited Company filed a free writing prospectus on November 9, 2026, disclosing the pricing terms for two tranches of senior notes totaling $1,500,000,000, with settlement expected on November 24, 2026.

Nitish Kishor | 09 November 2026

Goldman Sachs Reports 6.5% Stake in Alpex Acquisition

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of Class A ordinary shares of Alpex Acquisition Corporation as of September 30, 2026.

Anjali Anand | 09 November 2026

Goldman Sachs Reports 3.7% Stake in People Inc. Common Stock

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common stock in People Incorporated as of September 30, 2026.

Aditi Sarkar | 09 November 2026

Goldman Sachs Reports 4.3% Stake in NETSTREIT Corp.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC on October 8, 2026, disclosing beneficial ownership of approximately 4.3% of NETSTREIT Corp.'s common stock as of September 30, 2026.

Aditi Sarkar | 09 November 2026

Goldman Sachs Reports Zero TNL Mediagene Stake at Sept. 30

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended beneficial ownership statement with the SEC on November 9, 2026, reporting zero beneficial ownership of ordinary shares of TNL Mediagene as of September 30, 2026.

Nitish Kishor | 09 November 2026

Goldman Sachs Reports 7.6% Stake in Pacific Biosciences

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of common stock in Pacific Biosciences of California, Inc. as of September 30, 2026.

Vinay Lochav | 09 November 2026

Goldman Sachs Reports 5.9% Stake in Oxford Industries

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5.9% of Oxford Industries, Inc. common stock as of September 30, 2026.

Manish Choudhary | 09 November 2026

Goldman Sachs Reports 5.4% Stake in Range Capital Acquisition

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of ordinary shares of Range Capital Acquisition Corp as of September 30, 2026.

Vinay Lochav | 09 November 2026

GS Finance Autocallable EURO STOXX 50 Notes Due 2029

GS Finance Corp. filed a Free Writing Prospectus on November 9, 2026, disclosing terms for Market Linked Securities that are autocallable with a fixed percentage buffered downside, linked to the EURO STOXX 50 Index and due November 26, 2029.

Nitish Kishor | 09 November 2026
Support

Hi! How can we help you today?

Loading…